CSIMarket
 


Mosaic Immunoengineering Inc   (PTSC)
Other Ticker:  
 
 

PTSC's Income from Cont. Operations Growth by Quarter and Year

Mosaic Immunoengineering Inc 's Income from Cont. Operations results by quarter and year




PTSC Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.54 -0.85 -0.63
III Quarter September -0.33 -0.15 -1.05 -0.12
II Quarter June 0.02 -0.93 -0.98 -0.10
I Quarter March -0.40 -0.76 -0.81 -0.10
FY   -0.71 -2.38 -3.69 -0.95



PTSC Income from Cont. Operations third quarter 2023 Y/Y Growth Comment
Mosaic Immunoengineering Inc in the third quarter 2023 recorded loss from continued operations of $ -0.33 millions.

According to the results reported in the third quarter 2023, Mosaic Immunoengineering Inc achieved the best Income from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Mosaic Immunoengineering Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2023.




PTSC Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mosaic Immunoengineering Inc 's third quarter 2023 Income from Cont. Operations $ -0.33 millions PTSC's Income Statement
Mosaic Immunoengineering Inc 's third quarter 2022 Income from Cont. Operations $ -0.15 millions Quarterly PTSC's Income Statement
New: More PTSC's historic Income from Cont. Operations Growth >>


PTSC Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Mosaic Immunoengineering Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTSC's III. Quarter Q/Q Income from Cont. Operations Comment
Recent results of -0.33 millions by Mosaic Immunoengineering Inc appear even more unfavourable compare to the 0.02 millions loss from continued operations in the second quarter.

Within Biotechnology & Pharmaceuticals industry Mosaic Immunoengineering Inc achieved highest sequential Income from Cont. Operations growth. While Mosaic Immunoengineering Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTSC's III. Quarter Q/Q Income from Cont. Operations Comment
Current loss from continued operations of -0.33 millions by Mosaic Immunoengineering Inc come out even less good compare to the loss from continued operations 0.02 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Mosaic Immunoengineering Inc achieved highest sequential Income from Cont. Operations growth. While Mosaic Immunoengineering Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Mosaic Immunoengineering Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -1.25 $ -1.07 $ -2.02 $ -2.38 $ -2.69
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Mosaic Immunoengineering Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Mosaic Immunoengineering Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
PTSC's Income from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for PTSC's Competitors
Income from Cont. Operations Growth for Mosaic Immunoengineering Inc 's Suppliers
Income from Cont. Operations Growth for PTSC's Customers

You may also want to know
PTSC's Annual Growth Rates PTSC's Profitability Ratios PTSC's Asset Turnover Ratio PTSC's Dividend Growth
PTSC's Roe PTSC's Valuation Ratios PTSC's Financial Strength Ratios PTSC's Dividend Payout Ratio
PTSC's Roa PTSC's Inventory Turnover Ratio PTSC's Growth Rates PTSC's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2023
Amphastar Pharmaceuticals Inc 210.08%$ 210.079 millions
Alpha Pro Tech Ltd 179.40%$ 179.399 millions
Viemed Healthcare Inc 176.68%$ 176.682 millions
Boston Scientific Corporation168.09%$ 168.085 millions
Cadre Holdings Inc 123.70%$ 123.700 millions
Lantheus Holdings Inc 115.50%$ 115.503 millions
Orasure Technologies Inc111.63%$ 111.625 millions
Fonar Corporation102.26%$ 102.264 millions
Electromed Inc 91.36%$ 91.358 millions
Davita Inc 87.84%$ 87.840 millions
Integer Holdings Corporation69.75%$ 69.752 millions
Merit Medical Systems Inc69.16%$ 69.159 millions
Align Technology inc 67.02%$ 67.025 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com